Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

UTI vs COCO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
UTI
Universal Technical Institute, Inc.

Education & Training Services

Consumer DefensiveNYSE • US
Market Cap$2.03B
5Y Perf.+424.4%
COCO
The Vita Coco Company, Inc.

Beverages - Non-Alcoholic

Consumer DefensiveNASDAQ • US
Market Cap$3.92B
5Y Perf.+408.4%

UTI vs COCO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
UTI logoUTI
COCO logoCOCO
IndustryEducation & Training ServicesBeverages - Non-Alcoholic
Market Cap$2.03B$3.92B
Revenue (TTM)$869M$659M
Net Income (TTM)$43M$83M
Gross Margin24.0%37.2%
Operating Margin6.3%14.7%
Forward P/E46.2x41.4x
Total Debt$279M$13M
Cash & Equiv.$127M$197M

UTI vs COCOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

UTI
COCO
StockOct 21May 26Return
Universal Technical… (UTI)100524.4+424.4%
The Vita Coco Compa… (COCO)100508.4+408.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: UTI vs COCO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: COCO leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Universal Technical Institute, Inc. is the stronger pick specifically for valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
UTI
Universal Technical Institute, Inc.
The Growth Play

UTI is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 14.0%, EPS growth 50.7%, 3Y rev CAGR 25.9%
  • 9.7% 10Y total return vs COCO's 407.7%
  • PEG 0.55 vs COCO's 2.75
Best for: growth exposure and long-term compounding
COCO
The Vita Coco Company, Inc.
The Income Pick

COCO carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • beta 0.65
  • Lower volatility, beta 0.65, Low D/E 3.9%, current ratio 3.62x
  • Beta 0.65, current ratio 3.62x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthCOCO logoCOCO18.2% revenue growth vs UTI's 14.0%
ValueUTI logoUTIPEG 0.55 vs 2.75
Quality / MarginsCOCO logoCOCO12.6% margin vs UTI's 4.9%
Stability / SafetyCOCO logoCOCOBeta 0.65 vs UTI's 0.89, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)COCO logoCOCO+96.1% vs UTI's +25.5%
Efficiency (ROA)COCO logoCOCO18.1% ROA vs UTI's 5.2%, ROIC 51.2% vs 14.3%

UTI vs COCO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

UTIUniversal Technical Institute, Inc.
FY 2022
Postsecondary Education
96.6%$405M
Other Segments
3.4%$14M
COCOThe Vita Coco Company, Inc.
FY 2025
Vita Coco Coconut Water
81.4%$496M
Private Label
14.5%$89M
Product and Service, Other
4.1%$25M

UTI vs COCO — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCOCOLAGGINGUTI

Income & Cash Flow (Last 12 Months)

COCO leads this category, winning 6 of 6 comparable metrics.

UTI and COCO operate at a comparable scale, with $869M and $659M in trailing revenue. COCO is the more profitable business, keeping 12.6% of every revenue dollar as net income compared to UTI's 4.9%. On growth, COCO holds the edge at +37.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUTI logoUTIUniversal Technic…COCO logoCOCOThe Vita Coco Com…
RevenueTrailing 12 months$869M$659M
EBITDAEarnings before interest/tax$78M$98M
Net IncomeAfter-tax profit$43M$83M
Free Cash FlowCash after capex$2M$65M
Gross MarginGross profit ÷ Revenue+24.0%+37.2%
Operating MarginEBIT ÷ Revenue+6.3%+14.7%
Net MarginNet income ÷ Revenue+4.9%+12.6%
FCF MarginFCF ÷ Revenue+0.2%+9.9%
Rev. Growth (YoY)Latest quarter vs prior year+6.7%+37.3%
EPS Growth (YoY)Latest quarter vs prior year-95.2%+61.3%
COCO leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

UTI leads this category, winning 6 of 7 comparable metrics.

At 32.7x trailing earnings, UTI trades at a 43% valuation discount to COCO's 57.7x P/E. Adjusting for growth (PEG ratio), UTI offers better value at 0.39x vs COCO's 3.83x — a lower PEG means you pay less per unit of expected earnings growth.

MetricUTI logoUTIUniversal Technic…COCO logoCOCOThe Vita Coco Com…
Market CapShares × price$2.0B$3.9B
Enterprise ValueMkt cap + debt − cash$2.2B$3.7B
Trailing P/EPrice ÷ TTM EPS32.67x57.68x
Forward P/EPrice ÷ next-FY EPS est.46.23x41.37x
PEG RatioP/E ÷ EPS growth rate0.39x3.83x
EV / EBITDAEnterprise value multiple15.56x44.62x
Price / SalesMarket cap ÷ Revenue2.43x6.43x
Price / BookPrice ÷ Book value/share6.26x12.42x
Price / FCFMarket cap ÷ FCF36.70x100.45x
UTI leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

COCO leads this category, winning 7 of 8 comparable metrics.

COCO delivers a 25.4% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $13 for UTI. COCO carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to UTI's 0.85x. On the Piotroski fundamental quality scale (0–9), UTI scores 7/9 vs COCO's 4/9, reflecting strong financial health.

MetricUTI logoUTIUniversal Technic…COCO logoCOCOThe Vita Coco Com…
ROE (TTM)Return on equity+13.0%+25.4%
ROA (TTM)Return on assets+5.2%+18.1%
ROICReturn on invested capital+14.3%+51.2%
ROCEReturn on capital employed+14.7%+27.4%
Piotroski ScoreFundamental quality 0–974
Debt / EquityFinancial leverage0.85x0.04x
Net DebtTotal debt minus cash$152M-$184M
Cash & Equiv.Liquid assets$127M$197M
Total DebtShort + long-term debt$279M$13M
Interest CoverageEBIT ÷ Interest expense166.10x
COCO leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

UTI leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in UTI five years ago would be worth $64,886 today (with dividends reinvested), compared to $50,769 for COCO. Over the past 12 months, COCO leads with a +96.1% total return vs UTI's +25.5%. The 3-year compound annual growth rate (CAGR) favors UTI at 82.0% vs COCO's 43.4% — a key indicator of consistent wealth creation.

MetricUTI logoUTIUniversal Technic…COCO logoCOCOThe Vita Coco Com…
YTD ReturnYear-to-date+48.6%+28.4%
1-Year ReturnPast 12 months+25.5%+96.1%
3-Year ReturnCumulative with dividends+503.3%+195.2%
5-Year ReturnCumulative with dividends+548.9%+407.7%
10-Year ReturnCumulative with dividends+970.1%+407.7%
CAGR (3Y)Annualised 3-year return+82.0%+43.4%
UTI leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

COCO leads this category, winning 2 of 2 comparable metrics.

COCO is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than UTI's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COCO currently trades 98.6% from its 52-week high vs UTI's 91.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUTI logoUTIUniversal Technic…COCO logoCOCOThe Vita Coco Com…
Beta (5Y)Sensitivity to S&P 5000.89x0.65x
52-Week HighHighest price in past year$40.41$69.58
52-Week LowLowest price in past year$21.29$30.54
% of 52W HighCurrent price vs 52-week peak+91.4%+98.6%
RSI (14)Momentum oscillator 0–10059.776.9
Avg Volume (50D)Average daily shares traded594K1.4M
COCO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates UTI as "Buy" and COCO as "Buy". Consensus price targets imply 32.7% upside for UTI (target: $49) vs -1.1% for COCO (target: $68).

MetricUTI logoUTIUniversal Technic…COCO logoCOCOThe Vita Coco Com…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$49.00$67.86
# AnalystsCovering analysts1114
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.3%
Insufficient data to determine a leader in this category.
Key Takeaway

COCO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). UTI leads in 2 (Valuation Metrics, Total Returns).

Best OverallThe Vita Coco Company, Inc. (COCO)Leads 3 of 6 categories
Loading custom metrics...

UTI vs COCO: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is UTI or COCO a better buy right now?

For growth investors, The Vita Coco Company, Inc.

(COCO) is the stronger pick with 18. 2% revenue growth year-over-year, versus 14. 0% for Universal Technical Institute, Inc. (UTI). Universal Technical Institute, Inc. (UTI) offers the better valuation at 32. 7x trailing P/E (46. 2x forward), making it the more compelling value choice. Analysts rate Universal Technical Institute, Inc. (UTI) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — UTI or COCO?

On trailing P/E, Universal Technical Institute, Inc.

(UTI) is the cheapest at 32. 7x versus The Vita Coco Company, Inc. at 57. 7x. On forward P/E, The Vita Coco Company, Inc. is actually cheaper at 41. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Universal Technical Institute, Inc. wins at 0. 55x versus The Vita Coco Company, Inc. 's 2. 75x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — UTI or COCO?

Over the past 5 years, Universal Technical Institute, Inc.

(UTI) delivered a total return of +548. 9%, compared to +407. 7% for The Vita Coco Company, Inc. (COCO). Over 10 years, the gap is even starker: UTI returned +970. 1% versus COCO's +407. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — UTI or COCO?

By beta (market sensitivity over 5 years), The Vita Coco Company, Inc.

(COCO) is the lower-risk stock at 0. 65β versus Universal Technical Institute, Inc. 's 0. 89β — meaning UTI is approximately 37% more volatile than COCO relative to the S&P 500. On balance sheet safety, The Vita Coco Company, Inc. (COCO) carries a lower debt/equity ratio of 4% versus 85% for Universal Technical Institute, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — UTI or COCO?

By revenue growth (latest reported year), The Vita Coco Company, Inc.

(COCO) is pulling ahead at 18. 2% versus 14. 0% for Universal Technical Institute, Inc. (UTI). On earnings-per-share growth, the picture is similar: Universal Technical Institute, Inc. grew EPS 50. 7% year-over-year, compared to 26. 6% for The Vita Coco Company, Inc.. Over a 3-year CAGR, UTI leads at 25. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — UTI or COCO?

The Vita Coco Company, Inc.

(COCO) is the more profitable company, earning 11. 7% net margin versus 7. 5% for Universal Technical Institute, Inc. — meaning it keeps 11. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COCO leads at 13. 6% versus 10. 0% for UTI. At the gross margin level — before operating expenses — UTI leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is UTI or COCO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Universal Technical Institute, Inc. (UTI) is the more undervalued stock at a PEG of 0. 55x versus The Vita Coco Company, Inc. 's 2. 75x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Vita Coco Company, Inc. (COCO) trades at 41. 4x forward P/E versus 46. 2x for Universal Technical Institute, Inc. — 4. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UTI: 32. 7% to $49. 00.

08

Which pays a better dividend — UTI or COCO?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is UTI or COCO better for a retirement portfolio?

For long-horizon retirement investors, Universal Technical Institute, Inc.

(UTI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), +970. 1% 10Y return). Both have compounded well over 10 years (UTI: +970. 1%, COCO: +407. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between UTI and COCO?

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: UTI is a small-cap quality compounder stock; COCO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

UTI

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 14%
Run This Screen
Stocks Like

COCO

High-Growth Compounder

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 18%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform UTI and COCO on the metrics below

Revenue Growth>
%
(UTI: 6.7% · COCO: 37.3%)
Net Margin>
%
(UTI: 4.9% · COCO: 12.6%)
P/E Ratio<
x
(UTI: 32.7x · COCO: 57.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.